Wei S.-H.WANG-TSO LEE2020-12-182020-12-1820150929-6646https://www.scopus.com/inward/record.uri?eid=2-s2.0-84951908718&doi=10.1016%2fj.jfma.2015.07.015&partnerID=40&md5=a2b8f2398abcbd505d2378e84935b99ahttps://scholars.lib.ntu.edu.tw/handle/123456789/527380Epilepsy in children is occasionally associated with variable comorbidities although the frequency of such comorbidity is often difficult to determine. They can be divided into three categories: neurological, psychological, and physical comorbidities. The goal of the present review is to discuss the reported comorbidities of epilepsy in children. The possible mechanisms and associated risk factors-including the effect of seizure frequency and seizure control, types of epilepsy, age of seizure onset, duration of illness, and the possible detrimental effect of antiepileptic drugs-will be described. ? 2015.Children; Comorbidity; Epilepsy[SDGs]SDG3anticonvulsive agent; anticonvulsant therapy; autism; benign childhood epilepsy; body height; bone density; bone disease; carnitine deficiency; cognitive defect; comorbidity; disease duration; dyslipidemia; family conflict; growth hormone deficiency; human; hypothyroidism; immunopathology; language disability; mental disease; migraine; mood disorder; onset age; osteolysis; ovary polycystic disease; psychosocial care; psychosocial disorder; Review; seizure; sexual maturation; sleep disorder; social stress; therapy effect; treatment duration; weight change; Autism Spectrum Disorder; Bone Diseases, Metabolic; child; classification; Cognitive Dysfunction; comorbidity; complication; epilepsy; risk factor; Anticonvulsants; Autism Spectrum Disorder; Bone Diseases, Metabolic; Child; Cognitive Dysfunction; Comorbidity; Epilepsy; Humans; Risk Factorsreview10.1016/j.jfma.2015.07.015263411502-s2.0-84951908718